Ultragenyx Pharmaceutical | RARE - Trade Creditors


Ultragenyx Pharmaceutical reported $39M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Immunic USD 11.01M 873K Mar/2026
Insmed USD 74.55M 1.18M Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Kyowa Hakko Kirin JPY 125.29B 17.7B Jun/2026
MacroGenics USD 3.44M 845K Jun/2026
Moderna USD 167M 6M Jun/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026